CUL7
Basic information
Region (hg38): 6:43037617-43053943
Previous symbols: [ "KIAA0076" ]
Links
Phenotypes
GenCC
Source:
- 3M syndrome 1 (Definitive), mode of inheritance: AR
- 3M syndrome 1 (Definitive), mode of inheritance: AR
- 3-M syndrome (Supportive), mode of inheritance: AR
- 3M syndrome 1 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Three M syndrome 1 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal | 16142236; 17675530; 19225462; 21166787; 22624670; 22974575 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (46 variants)
- 3M syndrome 1 (14 variants)
- 3-M syndrome (3 variants)
- Inborn genetic diseases (2 variants)
- CUL7-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CUL7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 117 | 10 | 151 | ||
missense | 295 | 10 | 12 | 322 | ||
nonsense | 27 | 31 | ||||
start loss | 0 | |||||
frameshift | 24 | 34 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 10 | 12 | ||||
splice region | 11 | 15 | 1 | 27 | ||
non coding | 13 | 49 | 24 | 86 | ||
Total | 54 | 24 | 341 | 177 | 46 |
Highest pathogenic variant AF is 0.0000394
Variants in CUL7
This is a list of pathogenic ClinVar variants found in the CUL7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-43037631-T-C | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
6-43037692-C-A | Uncertain significance (Oct 24, 2022) | |||
6-43037692-C-T | 3M syndrome 1 | Uncertain significance (Jul 10, 2023) | ||
6-43037697-G-A | not specified • 3M syndrome 1 | Benign (Jan 25, 2024) | ||
6-43037705-A-C | Inborn genetic diseases | Uncertain significance (Feb 21, 2022) | ||
6-43037713-G-A | 3M syndrome 1 | Uncertain significance (Dec 21, 2022) | ||
6-43037744-G-A | 3M syndrome 1 | Uncertain significance (Apr 24, 2022) | ||
6-43037744-G-C | 3M syndrome 1 | Uncertain significance (Aug 26, 2019) | ||
6-43037754-CTG-C | 3M syndrome 1 | Uncertain significance (Sep 13, 2019) | ||
6-43037756-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
6-43037756-G-T | Inborn genetic diseases | Uncertain significance (Feb 22, 2023) | ||
6-43037774-G-A | Uncertain significance (Aug 12, 2021) | |||
6-43037774-G-T | Uncertain significance (Jan 06, 2023) | |||
6-43037776-G-A | Inborn genetic diseases | Uncertain significance (Mar 25, 2024) | ||
6-43037813-C-T | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
6-43037830-A-G | Inborn genetic diseases | Uncertain significance (Jul 25, 2024) | ||
6-43037834-T-G | Inborn genetic diseases | Uncertain significance (Sep 03, 2024) | ||
6-43037836-A-G | Inborn genetic diseases | Uncertain significance (Oct 17, 2024) | ||
6-43037848-T-C | Uncertain significance (Feb 10, 2021) | |||
6-43037849-A-G | Uncertain significance (Aug 25, 2017) | |||
6-43037850-G-A | 3M syndrome 1 | Benign/Likely benign (Feb 01, 2024) | ||
6-43037866-C-T | Inborn genetic diseases | Uncertain significance (Nov 15, 2024) | ||
6-43037868-G-A | CUL7-related disorder | Likely benign (Apr 01, 2022) | ||
6-43037871-G-A | not specified | Benign/Likely benign (Oct 06, 2023) | ||
6-43037873-C-CA | - | no classification for the single variant (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CUL7 | protein_coding | protein_coding | ENST00000535468 | 26 | 16329 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.59e-21 | 1.00 | 125647 | 0 | 101 | 125748 | 0.000402 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.543 | 959 | 1.01e+3 | 0.952 | 0.0000653 | 11513 |
Missense in Polyphen | 310 | 339.81 | 0.91228 | 3945 | ||
Synonymous | -0.212 | 430 | 424 | 1.01 | 0.0000266 | 3706 |
Loss of Function | 3.59 | 47 | 82.0 | 0.573 | 0.00000460 | 878 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00157 | 0.00156 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000652 | 0.000653 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000223 | 0.000220 |
Middle Eastern | 0.000652 | 0.000653 |
South Asian | 0.000728 | 0.000719 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Core component of the 3M and Cul7-RING(FBXW8) complexes, which mediates the ubiquitination of target proteins. Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695). Interaction with CUL9 is required to inhibit CUL9 activity and ubiquitination of BIRC5 (PubMed:24793696). Core component of a Cul7-RING ubiquitin-protein ligase with FBXW8, which mediates ubiquitination and consequent degradation of target proteins such as GORASP1, IRS1 and MAP4K1/HPK1 (PubMed:21572988, PubMed:24362026). Ubiquitination of GORASP1 regulates Golgi morphogenesis and dendrite patterning in brain (PubMed:21572988). Mediates ubiquitination and degradation of IRS1 in a mTOR-dependent manner: the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2) (PubMed:18498745). The Cul7-RING(FBXW8) complex also mediates ubiquitination of MAP4K1/HPK1: recognizes and binds autophosphorylated MAP4K1/HPK1, leading to its degradation, thereby affecting cell proliferation and differentiation (PubMed:24362026). Acts as a regulator in trophoblast cell epithelial-mesenchymal transition and placental development (PubMed:20139075). Does not promote polyubiquitination and proteasomal degradation of p53/TP53 (PubMed:16547496, PubMed:17332328). While the Cul7-RING(FBXW8) and the 3M complexes are associated and involved in common processes, CUL7 and the Cul7-RING(FBXW8) complex may be have additional functions. {ECO:0000269|PubMed:16547496, ECO:0000269|PubMed:17332328, ECO:0000269|PubMed:18498745, ECO:0000269|PubMed:20139075, ECO:0000269|PubMed:21572988, ECO:0000269|PubMed:24362026, ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.;
- Disease
- DISEASE: 3M syndrome 1 (3M1) [MIM:273750]: An autosomal recessive disorder characterized by severe pre- and postnatal growth retardation, facial dysmorphism, large head circumference, and normal intelligence and endocrine function. Skeletal changes include long slender tubular bones and tall vertebral bodies. {ECO:0000269|PubMed:16142236, ECO:0000269|PubMed:17675530, ECO:0000269|PubMed:23018678}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);XBP1(S) activates chaperone genes;Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.253
- rvis_EVS
- -1.53
- rvis_percentile_EVS
- 3.39
Haploinsufficiency Scores
- pHI
- 0.166
- hipred
- Y
- hipred_score
- 0.711
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.754
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cul7
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype; skeleton phenotype;
Gene ontology
- Biological process
- microtubule cytoskeleton organization;mitotic cytokinesis;vasculogenesis;epithelial to mesenchymal transition;placenta development;proteolysis;ubiquitin-dependent protein catabolic process;Golgi organization;regulation of mitotic nuclear division;viral process;protein ubiquitination;IRE1-mediated unfolded protein response;post-translational protein modification;positive regulation of dendrite morphogenesis
- Cellular component
- anaphase-promoting complex;cytoplasm;Golgi apparatus;centrosome;cytosol;Cul7-RING ubiquitin ligase complex;perinuclear region of cytoplasm;3M complex
- Molecular function
- protein binding;ubiquitin protein ligase binding